-
1
-
-
84856566783
-
Trends in incidence of small cell lung cancer and all lung cancer
-
Riaz SP, Lüchtenborg M, Coupland VH, Spicer J, Peake MD and Møller H. Trends in incidence of small cell lung cancer and all lung cancer. Lung Cancer. 2012; 75:280-284.
-
(2012)
Lung Cancer
, vol.75
, pp. 280-284
-
-
Riaz, S.P.1
Lüchtenborg, M.2
Coupland, V.H.3
Spicer, J.4
Peake, M.D.5
Møller, H.6
-
2
-
-
0037616996
-
-
National Cancer Institute; Bethesda, MD: 2007. Available at, seer cancer gov/csr/1975-2001
-
Ries L, Eisner M, Kosary C, Hankey B, Miller B, Clegg L, Mariotto A, Feuer E and Edwards B. SEER Cancer Statistics Review, 1975-2004. National Cancer Institute; Bethesda, MD: 2007. Available at: seer cancer gov/csr/1975-2001. 2007.
-
(2007)
SEER Cancer Statistics Review, 1975-2004
-
-
Ries, L.1
Eisner, M.2
Kosary, C.3
Hankey, B.4
Miller, B.5
Clegg, L.6
Mariotto, A.7
Feuer, E.8
Edwards, B.9
-
3
-
-
0037504527
-
Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival
-
Videtic GM, Stitt LW, Dar AR, Kocha WI, Tomiak AT, Truong PT, Vincent MD and Edward WY. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. Journal of Clinical Oncology. 2003; 21:1544-1549.
-
(2003)
Journal of Clinical Oncology
, vol.21
, pp. 1544-1549
-
-
Videtic, G.M.1
Stitt, L.W.2
Dar, A.R.3
Kocha, W.I.4
Tomiak, A.T.5
Truong, P.T.6
Vincent, M.D.7
Edward, W.Y.8
-
4
-
-
79961127734
-
Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer
-
Wolfson AH, Bae K, Komaki R, Meyers C, Movsas B, Le Pechoux C, Werner-Wasik M, Videtic GM, Garces YI and Choy H. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. International Journal of Radiation Oncology Biology Physics. 2011; 81:77-84.
-
(2011)
International Journal of Radiation Oncology Biology Physics
, vol.81
, pp. 77-84
-
-
Wolfson, A.H.1
Bae, K.2
Komaki, R.3
Meyers, C.4
Movsas, B.5
Le Pechoux, C.6
Werner-Wasik, M.7
Videtic, G.M.8
Garces, Y.I.9
Choy, H.10
-
5
-
-
79952408951
-
Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer
-
Foster NR, Qi Y, Shi Q, Krook JE, Kugler JW, Jett JR, Molina JR, Schild SE, Adjei AA and Mandrekar SJ. Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer. Cancer. 2011; 117:1262-1271.
-
(2011)
Cancer
, vol.117
, pp. 1262-1271
-
-
Foster, N.R.1
Qi, Y.2
Shi, Q.3
Krook, J.E.4
Kugler, J.W.5
Jett, J.R.6
Molina, J.R.7
Schild, S.E.8
Adjei, A.A.9
Mandrekar, S.J.10
-
7
-
-
84927132236
-
microRNA: Self-regulated transcription
-
Seton-Rogers S. microRNA: Self-regulated transcription. Nature Reviews Cancer. 2014; 14:9-9.
-
(2014)
Nature Reviews Cancer
, vol.14
, pp. 9-9
-
-
Seton-Rogers, S.1
-
8
-
-
84901069935
-
Plasma microRNAs as biomarkers for myotonic dystrophy type 1
-
Perfetti A, Greco S, Bugiardini E, Cardani R, Gaia P, Gaetano C, Meola G and Martelli F. Plasma microRNAs as biomarkers for myotonic dystrophy type 1. Neuromuscular Disorders. 2014; 24:509-515.
-
(2014)
Neuromuscular Disorders
, vol.24
, pp. 509-515
-
-
Perfetti, A.1
Greco, S.2
Bugiardini, E.3
Cardani, R.4
Gaia, P.5
Gaetano, C.6
Meola, G.7
Martelli, F.8
-
11
-
-
84927612665
-
The role of hypoxia-inducible factor-2 in digestive system cancers
-
Zhao J, Du F, Shen G, Zheng F and Xu B. The role of hypoxia-inducible factor-2 in digestive system cancers. Cell death & disease. 2015; 6:e1600.
-
(2015)
Cell death & disease
, vol.6
, pp. e1600
-
-
Zhao, J.1
Du, F.2
Shen, G.3
Zheng, F.4
Xu, B.5
-
12
-
-
84897351790
-
c-Myc-mediated repression of miR-15-16 in hypoxia is induced by increased HIF-2α and promotes tumor angiogenesis and metastasis by upregulating FGF2
-
Xue G, Yan H, Zhang Y, Hao L, Zhu X, Mei Q and Sun S. c-Myc-mediated repression of miR-15-16 in hypoxia is induced by increased HIF-2α and promotes tumor angiogenesis and metastasis by upregulating FGF2. Oncogene. 2015; 34:1393-406.
-
(2015)
Oncogene
, vol.34
, pp. 1393-1406
-
-
Xue, G.1
Yan, H.2
Zhang, Y.3
Hao, L.4
Zhu, X.5
Mei, Q.6
Sun, S.7
-
13
-
-
84911488807
-
Knockdown of protein tyrosine phosphatase receptor U inhibits growth and motility of gastric cancer cells
-
Liu Y, Zhu Z, Xiong Z, Zheng J, Hu Z and Qiu J. Knockdown of protein tyrosine phosphatase receptor U inhibits growth and motility of gastric cancer cells. International journal of clinical and experimental pathology. 2014; 7:5750.
-
(2014)
International journal of clinical and experimental pathology
, vol.7
, pp. 5750
-
-
Liu, Y.1
Zhu, Z.2
Xiong, Z.3
Zheng, J.4
Hu, Z.5
Qiu, J.6
-
14
-
-
84905694120
-
Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility
-
Zhu Z, Liu Y, Li K, Liu J, Wang H, Sun B, Xiong Z, Jiang H, Zheng J and Hu Z. Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility. Carcinogenesis. 2014; 35:1901-1910.
-
(2014)
Carcinogenesis
, vol.35
, pp. 1901-1910
-
-
Zhu, Z.1
Liu, Y.2
Li, K.3
Liu, J.4
Wang, H.5
Sun, B.6
Xiong, Z.7
Jiang, H.8
Zheng, J.9
Hu, Z.10
-
15
-
-
33744960878
-
Protein-tyrosine phosphatase PCP-2 inhibits β-catenin signaling and increases E-cadherin-dependent cell adhesion
-
Yan H-X, Yang W, Zhang R, Chen L, Tang L, Zhai B, Liu S-Q, Cao H-F, Man X-B and Wu H-P. Protein-tyrosine phosphatase PCP-2 inhibits β-catenin signaling and increases E-cadherin-dependent cell adhesion. Journal of Biological Chemistry. 2006; 281:15423-15433.
-
(2006)
Journal of Biological Chemistry
, vol.281
, pp. 15423-15433
-
-
Yan, H.-X.1
Yang, W.2
Zhang, R.3
Chen, L.4
Tang, L.5
Zhai, B.6
Liu, S.-Q.7
Cao, H.-F.8
Man, X.-B.9
Wu, H.-P.10
-
16
-
-
84924916000
-
Protein tyrosine phosphatase receptor type O expression in the tumor niche correlates with reduced tumor growth, angiogenesis, circulating tumor cells and metastasis of breast cancer
-
Liu Z, Hou J, Ren L, He J, Sun B, Sun L-Z and Wang S. Protein tyrosine phosphatase receptor type O expression in the tumor niche correlates with reduced tumor growth, angiogenesis, circulating tumor cells and metastasis of breast cancer. Oncology reports. 2015; 33:1908-1914.
-
(2015)
Oncology reports
, vol.33
, pp. 1908-1914
-
-
Liu, Z.1
Hou, J.2
Ren, L.3
He, J.4
Sun, B.5
Sun, L.-Z.6
Wang, S.7
-
17
-
-
84655161946
-
HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression
-
Keith B, Johnson RS and Simon MC. HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer. 2012; 12:9-22.
-
(2012)
Nat Rev Cancer
, vol.12
, pp. 9-22
-
-
Keith, B.1
Johnson, R.S.2
Simon, M.C.3
-
18
-
-
80155133113
-
Tumour suppressor function of protein tyrosine phosphatase receptor-T
-
Scott A and Wang Z. Tumour suppressor function of protein tyrosine phosphatase receptor-T. Biosci Rep. 2011; 31:303-307.
-
(2011)
Biosci Rep
, vol.31
, pp. 303-307
-
-
Scott, A.1
Wang, Z.2
-
19
-
-
68849102685
-
HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice
-
Kim WY, Perera S, Zhou B, Carretero J, Yeh JJ, Heathcote SA, Jackson AL, Nikolinakos P, Ospina B, Naumov G, Brandstetter KA, Weigman VJ, Zaghlul S, Hayes DN, Padera RF, Heymach JV, et al. HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice. J Clin Invest. 2009; 119:2160-2170.
-
(2009)
J Clin Invest
, vol.119
, pp. 2160-2170
-
-
Kim, W.Y.1
Perera, S.2
Zhou, B.3
Carretero, J.4
Yeh, J.J.5
Heathcote, S.A.6
Jackson, A.L.7
Nikolinakos, P.8
Ospina, B.9
Naumov, G.10
Brandstetter, K.A.11
Weigman, V.J.12
Zaghlul, S.13
Hayes, D.N.14
Padera, R.F.15
Heymach, J.V.16
-
21
-
-
84869741959
-
Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review)
-
Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D and Musolino C. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). Int J Oncol. 2012; 41:1897-1912.
-
(2012)
Int J Oncol
, vol.41
, pp. 1897-1912
-
-
Allegra, A.1
Alonci, A.2
Campo, S.3
Penna, G.4
Petrungaro, A.5
Gerace, D.6
Musolino, C.7
-
22
-
-
84863229384
-
Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer
-
Liu R, Chen X, Du Y, Yao W, Shen L, Wang C, Hu Z, Zhuang R, Ning G and Zhang C. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clinical chemistry. 2012; 58:610-618.
-
(2012)
Clinical chemistry
, vol.58
, pp. 610-618
-
-
Liu, R.1
Chen, X.2
Du, Y.3
Yao, W.4
Shen, L.5
Wang, C.6
Hu, Z.7
Zhuang, R.8
Ning, G.9
Zhang, C.10
-
23
-
-
84969295541
-
Serum MicroRNAs as biomarkers in early stage non-small cell lung cancer
-
Ye Y, Wang Y, Roth J and Wu X. Serum MicroRNAs as biomarkers in early stage non-small cell lung cancer. Cancer Research. 2014; 74:298-298.
-
(2014)
Cancer Research
, vol.74
, pp. 298-298
-
-
Ye, Y.1
Wang, Y.2
Roth, J.3
Wu, X.4
-
24
-
-
78149360436
-
Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor
-
Wang F, Zheng Z, Guo J and Ding X. Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol Oncol. 2010; 119:586-593.
-
(2010)
Gynecol Oncol
, vol.119
, pp. 586-593
-
-
Wang, F.1
Zheng, Z.2
Guo, J.3
Ding, X.4
-
25
-
-
78649837502
-
Circulating miRNAs are correlated with tumor progression in prostate cancer
-
Brase JC, Johannes M, Schlomm T, Falth M, Haese A, Steuber T, Beissbarth T, Kuner R and Sultmann H. Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer. 2011; 128:608-616.
-
(2011)
Int J Cancer
, vol.128
, pp. 608-616
-
-
Brase, J.C.1
Johannes, M.2
Schlomm, T.3
Falth, M.4
Haese, A.5
Steuber, T.6
Beissbarth, T.7
Kuner, R.8
Sultmann, H.9
-
26
-
-
84903186567
-
MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A
-
Wang N, Zhou Y, Zheng L and Li H. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A. Gynecol Oncol. 2014; 34:129-37.
-
(2014)
Gynecol Oncol
, vol.34
, pp. 129-137
-
-
Wang, N.1
Zhou, Y.2
Zheng, L.3
Li, H.4
-
27
-
-
84895923572
-
Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer
-
Toiyama Y, Hur K, Tanaka K, Inoue Y, Kusunoki M, Boland CR and Goel A. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer. Ann Surg. 2014; 259:735-743.
-
(2014)
Ann Surg
, vol.259
, pp. 735-743
-
-
Toiyama, Y.1
Hur, K.2
Tanaka, K.3
Inoue, Y.4
Kusunoki, M.5
Boland, C.R.6
Goel, A.7
-
28
-
-
84902960997
-
Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients
-
Teixeira AL, Ferreira M, Silva J, Gomes M, Dias F, Santos JI, Maurício J, Lobo F and Medeiros R. Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients. Tumor Biology. 2014; 35:4057-4066.
-
(2014)
Tumor Biology
, vol.35
, pp. 4057-4066
-
-
Teixeira, A.L.1
Ferreira, M.2
Silva, J.3
Gomes, M.4
Dias, F.5
Santos, J.I.6
Maurício, J.7
Lobo, F.8
Medeiros, R.9
-
29
-
-
84872870630
-
Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma
-
Yang M, Liu R, Sheng J, Liao J, Wang Y, Pan E, Guo W, Pu Y and Yin L. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma. Oncol Rep. 2013; 29:169-176.
-
(2013)
Oncol Rep
, vol.29
, pp. 169-176
-
-
Yang, M.1
Liu, R.2
Sheng, J.3
Liao, J.4
Wang, Y.5
Pan, E.6
Guo, W.7
Pu, Y.8
Yin, L.9
-
30
-
-
84875857459
-
miR-574-5p negatively regulates Qki6/7 to impact β-catenin/Wnt signalling and the development of colorectal cancer
-
Ji S, Ye G, Zhang J, Wang L, Wang T, Wang Z, Zhang T, Wang G, Guo Z and Luo Y. miR-574-5p negatively regulates Qki6/7 to impact β-catenin/Wnt signalling and the development of colorectal cancer. Gut. 2013; 62:716-26.
-
(2013)
Gut
, vol.62
, pp. 716-726
-
-
Ji, S.1
Ye, G.2
Zhang, J.3
Wang, L.4
Wang, T.5
Wang, Z.6
Zhang, T.7
Wang, G.8
Guo, Z.9
Luo, Y.10
-
31
-
-
79951771769
-
miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer
-
Foss KM, Sima C, Ugolini D, Neri M, Allen KE and Weiss GJ. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol. 2011; 6:482-488.
-
(2011)
J Thorac Oncol
, vol.6
, pp. 482-488
-
-
Foss, K.M.1
Sima, C.2
Ugolini, D.3
Neri, M.4
Allen, K.E.5
Weiss, G.J.6
-
32
-
-
77955093873
-
MicroRNA 92a-2*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer
-
Ranade AR, Cherba D, Sridhar S, Richardson P, Webb C, Paripati A, Bowles B and Weiss GJ. MicroRNA 92a-2*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer. J Thorac Oncol. 2010; 5:1273-1278.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 1273-1278
-
-
Ranade, A.R.1
Cherba, D.2
Sridhar, S.3
Richardson, P.4
Webb, C.5
Paripati, A.6
Bowles, B.7
Weiss, G.J.8
-
33
-
-
84868323256
-
MicroRNA-574-5p was pivotal for TLR9 signaling enhanced tumor progression via down-regulating checkpoint suppressor 1 in human lung cancer
-
Li Q, Li X, Guo Z, Xu F, Xia J, Liu Z and Ren T. MicroRNA-574-5p was pivotal for TLR9 signaling enhanced tumor progression via down-regulating checkpoint suppressor 1 in human lung cancer. PLoS ONE. 2012; 7:e48278.
-
(2012)
PLoS ONE
, vol.7
, pp. e48278
-
-
Li, Q.1
Li, X.2
Guo, Z.3
Xu, F.4
Xia, J.5
Liu, Z.6
Ren, T.7
-
34
-
-
52049121293
-
Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue
-
Wong T-S, Liu X-B, Wong BY-H, Ng RW-M, Yuen AP-W and Wei WI. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clinical Cancer Research. 2008; 14:2588-2592.
-
(2008)
Clinical Cancer Research
, vol.14
, pp. 2588-2592
-
-
Wong, T.-S.1
Liu, X.-B.2
Wong, B.Y.-H.3
Ng, R.W.-M.4
Yuen, A.P.-W.5
Wei, W.I.6
-
35
-
-
63649123792
-
Mature miR-184 and squamous cell carcinoma of the tongue
-
Wong T-S, Ho W-K, Chan J, Ng R and Wei WI. Mature miR-184 and squamous cell carcinoma of the tongue. ScientificWorldJournal. 2009; 9:130-132.
-
(2009)
ScientificWorldJournal
, vol.9
, pp. 130-132
-
-
Wong, T.-S.1
Ho, W.-K.2
Chan, J.3
Ng, R.4
Wei, W.I.5
-
36
-
-
84895880911
-
Mir-184 post-transcriptionally regulates SOX7 expression and promotes cell proliferation in human hepatocellular carcinoma
-
Wu GG, Li WH, He WG, Jiang N, Zhang GX, Chen W, Yang HF, Liu QL, Huang YN, Zhang L, Zhang T and Zeng XC. Mir-184 post-transcriptionally regulates SOX7 expression and promotes cell proliferation in human hepatocellular carcinoma. PLoS ONE. 2014; 9:e88796.
-
(2014)
PLoS ONE
, vol.9
, pp. e88796
-
-
Wu, G.G.1
Li, W.H.2
He, W.G.3
Jiang, N.4
Zhang, G.X.5
Chen, W.6
Yang, H.F.7
Liu, Q.L.8
Huang, Y.N.9
Zhang, L.10
Zhang, T.11
Zeng, X.C.12
-
37
-
-
77951030589
-
MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2
-
Foley NH, Bray IM, Tivnan A, Bryan K, Murphy DM, Buckley PG, Ryan J, O'Meara A, O'Sullivan M and Stallings RL. MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2. Mol Cancer. 2010; 9:83.
-
(2010)
Mol Cancer
, vol.9
, pp. 83
-
-
Foley, N.H.1
Bray, I.M.2
Tivnan, A.3
Bryan, K.4
Murphy, D.M.5
Buckley, P.G.6
Ryan, J.7
O'Meara, A.8
O'Sullivan, M.9
Stallings, R.L.10
-
38
-
-
84887420799
-
Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma
-
Zhen Y, Liu Z, Yang H, Yu X, Wu Q, Hua S, Long X, Jiang Q, Song Y, Cheng C, Wang H, Zhao M, Fu Q, Lyu X, Chen Y, Fan Y, et al. Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma. Cell Death Dis. 2013; 4:e872.
-
(2013)
Cell Death Dis
, vol.4
, pp. e872
-
-
Zhen, Y.1
Liu, Z.2
Yang, H.3
Yu, X.4
Wu, Q.5
Hua, S.6
Long, X.7
Jiang, Q.8
Song, Y.9
Cheng, C.10
Wang, H.11
Zhao, M.12
Fu, Q.13
Lyu, X.14
Chen, Y.15
Fan, Y.16
-
39
-
-
84912561923
-
Candidate tumour suppressor CCDC19 regulates miR-184 direct targeting of C-Myc thereby suppressing cell growth in non-small cell lung cancers
-
Liu Z, Mai C, Yang H, Zhen Y, Yu X, Hua S, Wu Q, Jiang Q, Zhang Y, Song X and Fang W. Candidate tumour suppressor CCDC19 regulates miR-184 direct targeting of C-Myc thereby suppressing cell growth in non-small cell lung cancers. J Cell Mol Med. 2014; 18:1667-79.
-
(2014)
J Cell Mol Med
, vol.18
, pp. 1667-1679
-
-
Liu, Z.1
Mai, C.2
Yang, H.3
Zhen, Y.4
Yu, X.5
Hua, S.6
Wu, Q.7
Jiang, Q.8
Zhang, Y.9
Song, X.10
Fang, W.11
-
40
-
-
84906313950
-
Identification and consequences of miRNA-target interactions [mdash] beyond repression of gene expression
-
Hausser J and Zavolan M. Identification and consequences of miRNA-target interactions [mdash] beyond repression of gene expression. Nature Reviews Genetics. 2014; 15:599-612.
-
(2014)
Nature Reviews Genetics
, vol.15
, pp. 599-612
-
-
Hausser, J.1
Zavolan, M.2
-
41
-
-
0030010991
-
Characterization of PCP-2, a novel receptor protein tyrosine phosphatase of the MAM domain family
-
Wang H, Lian Z, Lerch MM, Chen Z, Xie W and Ullrich A. Characterization of PCP-2, a novel receptor protein tyrosine phosphatase of the MAM domain family. Oncogene. 1996; 12:2555-2562.
-
(1996)
Oncogene
, vol.12
, pp. 2555-2562
-
-
Wang, H.1
Lian, Z.2
Lerch, M.M.3
Chen, Z.4
Xie, W.5
Ullrich, A.6
-
42
-
-
33744960878
-
Protein-tyrosine phosphatase PCP-2 inhibits beta-catenin signaling and increases E-cadherin-dependent cell adhesion
-
Yan HX, Yang W, Zhang R, Chen L, Tang L, Zhai B, Liu SQ, Cao HF, Man XB, Wu HP, Wu MC and Wang HY. Protein-tyrosine phosphatase PCP-2 inhibits beta-catenin signaling and increases E-cadherin-dependent cell adhesion. J Biol Chem. 2006; 281:15423-15433.
-
(2006)
J Biol Chem
, vol.281
, pp. 15423-15433
-
-
Yan, H.X.1
Yang, W.2
Zhang, R.3
Chen, L.4
Tang, L.5
Zhai, B.6
Liu, S.Q.7
Cao, H.F.8
Man, X.B.9
Wu, H.P.10
Wu, M.C.11
Wang, H.Y.12
-
43
-
-
84857220124
-
The nonreceptor- type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer
-
Scrima M, De Marco C, De Vita F, Fabiani F, Franco R, Pirozzi G, Rocco G, Malanga D and Viglietto G. The nonreceptor- type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer. Am J Pathol. 2012; 180:1202-1214.
-
(2012)
Am J Pathol
, vol.180
, pp. 1202-1214
-
-
Scrima, M.1
De Marco, C.2
De Vita, F.3
Fabiani, F.4
Franco, R.5
Pirozzi, G.6
Rocco, G.7
Malanga, D.8
Viglietto, G.9
-
44
-
-
84655161946
-
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
-
Keith B, Johnson RS and Simon MC. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nature Reviews Cancer. 2011; 12:9-22.
-
(2011)
Nature Reviews Cancer
, vol.12
, pp. 9-22
-
-
Keith, B.1
Johnson, R.S.2
Simon, M.C.3
-
45
-
-
68849102685
-
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
-
Kim WY, Perera S, Zhou B, Carretero J, Yeh JJ, Heathcote SA, Jackson AL, Nikolinakos P, Ospina B and Naumov G. HIF2α cooperates with RAS to promote lung tumorigenesis in mice. The Journal of clinical investigation. 2009; 119:2160-2170.
-
(2009)
The Journal of clinical investigation
, vol.119
, pp. 2160-2170
-
-
Kim, W.Y.1
Perera, S.2
Zhou, B.3
Carretero, J.4
Yeh, J.J.5
Heathcote, S.A.6
Jackson, A.L.7
Nikolinakos, P.8
Ospina, B.9
Naumov, G.10
-
46
-
-
78650401560
-
HIF-2α enhances β-catenin/TCF-driven transcription by interacting with β-catenin
-
Choi H, Chun Y-S, Kim T-Y and Park J-W. HIF-2α enhances β-catenin/TCF-driven transcription by interacting with β-catenin. Cancer research. 2010; 70:10101-10111.
-
(2010)
Cancer research
, vol.70
, pp. 10101-10111
-
-
Choi, H.1
Chun, Y.-S.2
Kim, T.-Y.3
Park, J.-W.4
-
47
-
-
33746808398
-
Wnt/beta-catenin signaling in development and disease
-
Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006; 127:469-480.
-
(2006)
Cell
, vol.127
, pp. 469-480
-
-
Clevers, H.1
-
48
-
-
0035805117
-
The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin
-
Huber AH and Weis WI. The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell. 2001; 105:391-402.
-
(2001)
Cell
, vol.105
, pp. 391-402
-
-
Huber, A.H.1
Weis, W.I.2
-
49
-
-
1542347695
-
Convergence of Wnt, beta-catenin, and cadherin pathways
-
Nelson WJ and Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science. 2004; 303:1483-1487.
-
(2004)
Science
, vol.303
, pp. 1483-1487
-
-
Nelson, W.J.1
Nusse, R.2
-
50
-
-
70350532244
-
Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway
-
Saydam O, Shen Y, Wurdinger T, Senol O, Boke E, James MF, Tannous BA, Stemmer-Rachamimov AO, Yi M, Stephens RM, Fraefel C, Gusella JF, Krichevsky AM and Breakefield XO. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Mol Cell Biol. 2009; 29:5923-5940.
-
(2009)
Mol Cell Biol
, vol.29
, pp. 5923-5940
-
-
Saydam, O.1
Shen, Y.2
Wurdinger, T.3
Senol, O.4
Boke, E.5
James, M.F.6
Tannous, B.A.7
Stemmer-Rachamimov, A.O.8
Yi, M.9
Stephens, R.M.10
Fraefel, C.11
Gusella, J.F.12
Krichevsky, A.M.13
Breakefield, X.O.14
-
51
-
-
79955630404
-
Circulating microRNAs (miRNA) in serum of patients with prostate cancer
-
Mahn R, Heukamp LC, Rogenhofer S, von Ruecker A, Müller SC and Ellinger J. Circulating microRNAs (miRNA) in serum of patients with prostate cancer. Urology. 2011; 77:1265. e1269-1265. e1216.
-
(2011)
Urology
, vol.77
, pp. 1265.e1269-1265.e1276
-
-
Mahn, R.1
Heukamp, L.C.2
Rogenhofer, S.3
von Ruecker, A.4
Müller, S.C.5
Ellinger, J.6
-
52
-
-
84880842421
-
RNAi silencing targeting RNF8 enhances radiosensitivity of a non-small cell lung cancer cell line A549
-
Zhou H, Mu X, Chen J, Liu H, Shi W, Xing E, Yang K and Wu G. RNAi silencing targeting RNF8 enhances radiosensitivity of a non-small cell lung cancer cell line A549. International journal of radiation biology. 2013; 89:708-715.
-
(2013)
International journal of radiation biology
, vol.89
, pp. 708-715
-
-
Zhou, H.1
Mu, X.2
Chen, J.3
Liu, H.4
Shi, W.5
Xing, E.6
Yang, K.7
Wu, G.8
|